Skip to content
Sign in
Business opportunities for IKI Health

Compatibility /100

45/100

Medium potential

Why talk

  1. Both are based in Spain: shared local customers, investors and ecosystem.
  2. IKI Health likely needs first paying customers — Legit.Health (Spain, Seed, $5.7M raised, strong traction) can offer access to its customer base (inferred from public profile).
  3. Legit.Health has strong traction in the same sector: CE-marked medical device (ISO 13485), with partners listed such as NHS, SERMAS, SESPA, Sanitas, Adeslas, Novartis and Almirall — a proven go-to-market and customer relationships IKI Health can learn from or tap.

Score anatomy

Each segment is what one dimension adds, out of 100.

Needs ↔ offers8.8Market bridge15.7Customer potential8.5Sector synergy7.5Stage complementarity4.5

Dimension by dimension

Needs ↔ offers

8.8 / 25 pts

Legit.Health can help IKI Health.

  • IKI Health likely needs first paying customers — Legit.Health (Spain, Seed, $5.7M raised, strong traction) can offer access to its customer base (inferred from public profile).

Market bridge

15.7 / 45 pts

Distant markets.

  • Both are based in Spain: shared local customers, investors and ecosystem.

Customer potential

8.5 / 10 pts

Strong customer or channel potential.

  • Legit.Health has strong traction in the same sector: CE-marked medical device (ISO 13485), with partners listed such as NHS, SERMAS, SESPA, Sanitas, Adeslas, Novartis and Almirall — a proven go-to-market and customer relationships IKI Health can learn from or tap.

Sector synergy

7.5 / 10 pts

Same sector: peers.

  • Same sector (HealthTech): peer learning on regulation, pricing and investors; IKI Health works on FemTech / preventive and lifestyle medicine, Legit.Health on AI in dermatology (medical device).

Stage complementarity

4.5 / 10 pts

Weak stage signal.

  • Legit.Health has raised about $5.7M — investor introductions are realistic.
  • Stage not comparable (Undetermined / Seed).

How the score works

Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Market entry”: Needs ↔ offers 25, Market bridge 45, Customer potential 10, Sector synergy 10, Stage complementarity 10. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.

Potential blends compatibility (65%) with the mean global score of both startups (35%): 47/100 — high from 50, medium from 36.